The Fourth Hospital of Hebei Medical University, also known as the Tumor Hospital of Hebei , is a large and comprehensive hospital with the rank of Level Three and Grade A. With the focal point of work on the diagnosis and treatment of tumor,
Department of Biotherapy

    Comprehensive Strength: It is a department characterizing the treatment of tumor. It has 10 common sickbeds and 5 intensive care sickbeds.
    Indications and Features: adoptive cellular immunotherapy of all kinds of tumorCIKNK, stem cell treatment(autologous & allogenic), DC based vaccine therapy of tumor, gene therapy, molecular targeted therapy. The department has created new type of therapy combined with surgery, chemoradiotherapy, minimally invasive therapy while based on biotherapy in the aspect of the treatment of lung cancer, liver cancer, pancreatic cancer, prostate cancer, breast cancer, malignant melanoma, ovarian cancer, lymphoma, ascites and pleural effusion, lymphatic metastasis. It also provides the patients with one-stop and individual treatment means, and has achieved encouraging curative effects. The department organically integrates chemoradiotherapy and minimally invasive therapy while based on biotherapy. For patients with cancer in middle and advanced stage, their lifetime has been prolonged significantly, and their life quality has improved. Even some patients with cancer in early stage can be cured.

Copyright(c)2013 Fourth Hospital of Hebei Medical University All rights reserved